These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Predictors of myocardial contractile recovery after coronary revascularization in patients with prior myocardial infarction. Abdel-Salam Z; Nammas W Cardiovasc Revasc Med; 2010; 11(1):2-7. PubMed ID: 20129355 [TBL] [Abstract][Full Text] [Related]
6. Cardiac magnetic resonance imaging to assess and predict improvement of myocardial function after percutaneous coronary intervention: a new standard? Kutcher MA JACC Cardiovasc Interv; 2010 Apr; 3(4):401-2. PubMed ID: 20398867 [No Abstract] [Full Text] [Related]
7. Acute left ventricular remodeling following myocardial infarction: coupling of regional healing with remote extracellular matrix expansion. Chan W; Duffy SJ; White DA; Gao XM; Du XJ; Ellims AH; Dart AM; Taylor AJ JACC Cardiovasc Imaging; 2012 Sep; 5(9):884-93. PubMed ID: 22974800 [TBL] [Abstract][Full Text] [Related]
8. Is viability imaging still relevant in 2012? Chareonthaitawee P; Gersh BJ; Panza JA JACC Cardiovasc Imaging; 2012 May; 5(5):550-8. PubMed ID: 22595164 [No Abstract] [Full Text] [Related]
9. Restoration of left ventricular synchronous contraction after acute myocardial infarction by stem cell therapy: new insights into the therapeutic implication of stem cell therapy for acute myocardial infarction. Chang SA; Kim HK; Lee HY; Choi SY; Koo BK; Kim YJ; Sohn DW; Oh BH; Park YB; Choi YS; Kang HJ; Kim HS Heart; 2008 Aug; 94(8):995-1001. PubMed ID: 17974698 [TBL] [Abstract][Full Text] [Related]
10. Complete percutaneous revascularization for multivessel disease in patients with impaired left ventricular function: pre- and post-procedural evaluation by cardiac magnetic resonance imaging. Kirschbaum SW; Springeling T; Boersma E; Moelker A; van der Giessen WJ; Serruys PW; de Feyter PJ; van Geuns RJ JACC Cardiovasc Interv; 2010 Apr; 3(4):392-400. PubMed ID: 20398866 [TBL] [Abstract][Full Text] [Related]
11. Chronic urocortin 2 administration improves cardiac function and ameliorates cardiac remodeling after experimental myocardial infarction. Ellmers LJ; Scott NJ; Cameron VA; Richards AM; Rademaker MT J Cardiovasc Pharmacol; 2015 Mar; 65(3):269-75. PubMed ID: 25658462 [TBL] [Abstract][Full Text] [Related]
12. Real-time assessment of myocardial viability in the catheterization laboratory using the intracoronary electrograms recorded by the PTCA guidewire in patients with left ventricular dysfunction: comparison with delayed-enhancement magnetic resonance imaging. Petrucci E; Balian V; Bocchieri A JACC Cardiovasc Interv; 2014 Sep; 7(9):988-96. PubMed ID: 25129666 [TBL] [Abstract][Full Text] [Related]
18. Targeted deletion of nuclear factor kappaB p50 enhances cardiac remodeling and dysfunction following myocardial infarction. Timmers L; van Keulen JK; Hoefer IE; Meijs MF; van Middelaar B; den Ouden K; van Echteld CJ; Pasterkamp G; de Kleijn DP Circ Res; 2009 Mar; 104(5):699-706. PubMed ID: 19168865 [TBL] [Abstract][Full Text] [Related]
19. Concept and evaluation of hibernating myocardium. Rahimtoola SH Annu Rev Med; 1999; 50():75-86. PubMed ID: 10073264 [TBL] [Abstract][Full Text] [Related]
20. Physiological replacement of T3 improves left ventricular function in an animal model of myocardial infarction-induced congestive heart failure. Henderson KK; Danzi S; Paul JT; Leya G; Klein I; Samarel AM Circ Heart Fail; 2009 May; 2(3):243-52. PubMed ID: 19808346 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]